Proteomics Market Size, Share & Trends Analysis Report By Product (Services, Reagents & Consumables, Instruments), By Technology (Spectroscopy, Microarray), By Application, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 4 Business Days
Proteomics Market Growth & Trends
The global proteomics market size is expected to reach USD 70.56 billion by 2030, registering a CAGR of 13.5% over the forecast period, according to a new report by Grand View Research, Inc. The major factors driving theindustry growth are a rise in the demand for personalized medicine, an expansion of the pipeline of diagnostics utilizing proteomics mass spectrometry as well as biochip platforms, and discoveries based on genomics. Moreover, owing to the importance of proteomics in drug development, numerous pharmaceutical companies have established their own proteomic divisions, which are fueling the expansion of the global industry. For instance, in September 2021, Biognosys, announced the collaboration with Evotec, to promote the use of next-generation proteomics in clinical research and drug discovery.
The COVID-19 outbreak is expected to have a significant impact on the industry, as researchers across the world are concentrating on decoding 3D structures of SARS-CoV-2 proteins. To create effective medications and biological products against COVID-19, scientists are also attempting to examine the identification techniques, structures, characterization, and interactions of these proteins. The protein structure of virus proteins and their specific locations must be understood to find a novel, efficient target treatment medication for a virus. Therefore, it will increase the demand for drug development for COVID-19 and propel industry growth. The growing need for customized medications increased R&D spending, and technological developments related to proteomics components are also driving the market.
In addition, attractive market expansion potential for proteomics is anticipated to come from improvements in mass spectrometry-based proteomics and lucrative opportunities related to biomarker identification. Thereby, propelling the market growth.The introduction of new and improved proteomics techniques by major industry participants is projected to further accelerate the growth of the industry. For instance, to provide quick data acquisition for shotgun proteomics, Bruker Corp. introduced the timsTOF Pro system for Parallel Accumulation And Serial Fragmentation (PASEF) mass spectrometry in September 2017. This system uses proprietary Trapped Ion Mobility Spectrometry (TIMS) technology.Furthermore, proteomic research advancements have accelerated the detection of protein biomarkers, protein biochips & pharmacoproteomics, and proteomics-based molecular diagnostics, which have all made significant contributions to the development of personalized medicine.
Proteomics Market Report Highlights
Proteomics Market Growth & Trends
The global proteomics market size is expected to reach USD 70.56 billion by 2030, registering a CAGR of 13.5% over the forecast period, according to a new report by Grand View Research, Inc. The major factors driving theindustry growth are a rise in the demand for personalized medicine, an expansion of the pipeline of diagnostics utilizing proteomics mass spectrometry as well as biochip platforms, and discoveries based on genomics. Moreover, owing to the importance of proteomics in drug development, numerous pharmaceutical companies have established their own proteomic divisions, which are fueling the expansion of the global industry. For instance, in September 2021, Biognosys, announced the collaboration with Evotec, to promote the use of next-generation proteomics in clinical research and drug discovery.
The COVID-19 outbreak is expected to have a significant impact on the industry, as researchers across the world are concentrating on decoding 3D structures of SARS-CoV-2 proteins. To create effective medications and biological products against COVID-19, scientists are also attempting to examine the identification techniques, structures, characterization, and interactions of these proteins. The protein structure of virus proteins and their specific locations must be understood to find a novel, efficient target treatment medication for a virus. Therefore, it will increase the demand for drug development for COVID-19 and propel industry growth. The growing need for customized medications increased R&D spending, and technological developments related to proteomics components are also driving the market.
In addition, attractive market expansion potential for proteomics is anticipated to come from improvements in mass spectrometry-based proteomics and lucrative opportunities related to biomarker identification. Thereby, propelling the market growth.The introduction of new and improved proteomics techniques by major industry participants is projected to further accelerate the growth of the industry. For instance, to provide quick data acquisition for shotgun proteomics, Bruker Corp. introduced the timsTOF Pro system for Parallel Accumulation And Serial Fragmentation (PASEF) mass spectrometry in September 2017. This system uses proprietary Trapped Ion Mobility Spectrometry (TIMS) technology.Furthermore, proteomic research advancements have accelerated the detection of protein biomarkers, protein biochips & pharmacoproteomics, and proteomics-based molecular diagnostics, which have all made significant contributions to the development of personalized medicine.
Proteomics Market Report Highlights
- The reagent & consumables product segment held the largest share in 2021 due to rising research activities and the growing demand for protein separation from complicated mixtures for efficient analysis
- The clinical diagnostics application segment held a larger share in 2021 due to the development of sophisticated & specialized tests for early disease detection and disease management
- The spectroscopy technology segment held the maximum share in 2021 owing to the increasing usage in toxicological response profiling, basic molecular biology, biomarker identification, and pharmaceutical target screening
- North America led the global industry in 2021 due to a rise in demand for personalized drugs, the existence of major players operating in the U.S. and a highly developed healthcare research framework, and substantial expenditure on R&D
- Asia Pacific is expected to grow at the highest CAGRoverthe projected period due to factors, such as the rising prevalence of target diseases, increasing aging population, and rising proteomics adoption
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective
1.11.2 Objective
1.12 List of Abbreviations
CHAPTER 2 MARKET DEFINITIONS
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Summary
CHAPTER 4 GLOBAL PROTEOMICS MARKET VARIABLES, TRENDS, & SCOPE
4.1 Proteomics Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration And Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Rise In Geriatric Population Demanding Personalized Medicines
4.4.2 Growing Demand For Advanced Diagnostics In Targeted Disease Treatment
4.4.3 Growing Prevalence Of Target Diseases
4.4.4 Growing Demand For Therapeutic Medicines
4.4.5 Outbreak Of Covid-19
4.5 Market Restraint Analysis
4.5.1 Presence Of Ambiguous Regulatory Framework
4.5.2 High Procedure Costs
4.6 Porter’s Five Forces Analysis
4.7 SWOT Analysis
4.8 COVID-19 Impact Analysis
CHAPTER 5 PROTEOMICS MARKET - SEGMENT ANALYSIS, BY PRODUCT, 2018 - 2030 (USD MILLION)
5.1 Global Proteomics Market: Product Movement Analysis
5.2 Instruments
5.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Reagents & Consumables
5.3.1 Reagents & Consumables Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Services
5.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 PROTEOMICS MARKET - SEGMENT ANALYSIS, BY APPLICATION, 2018 - 2030 (USD MILLION)
6.1 Global Proteomics Market: Application Movement Analysis
6.2 Drug Discovery
6.2.1 Drug Discovery Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Clinical Diagnostics
6.3.1 Clinical Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Others
6.4.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 PROTEOMICS MARKET- SEGMENT ANALYSIS, BY TECHNOLOGY, 2018 - 2030 (USD MILLION)
7.1 Proteomics Market: Technology Movement Analysis
7.2 Microarray Instruments
7.2.1 Microarray Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 X-Ray Crystallography
7.3.1 X-Ray Crystallography Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4. Spectroscopy
7.4.1 Spectroscopy Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5 Chromatography
7.5.1 Chromatography Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6 Protein Fractionation Systems
7.6.1 Protein Fractionation Systems Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.7 Electrophoresis
7.7.1 Electrophoresis Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.8 Surface Plasma Resonance (Spr) Systems
7.8.1 Surface Plasma Resonance (Spr) Systems Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 8 PROTEOMICS MARKET: - SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
8.1 Proteomics Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.7. South Africa
8.7.1. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Public Companies
9.1.1 Company Market Position Analysis
9.1.2 Competitive Dashboard Analysis
9.1.3 Strategic Framework
9.2 Private Companies
9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
9.2.2 Regional Network Map
9.4 Company Profiles
9.4.1 ILLUMINA, INC.
9.4.1.1 Company Overview
9.4.1.2 Financial Performance
9.4.1.3 Product Benchmarking
9.4.1.4 Strategic Initiatives
9.4.2 AGILENT TECHNOLOGIES, INC.
9.4.2.1 Company Overview
9.4.2.2 Financial Performance
9.4.2.3 Product Benchmarking
9.4.2.4 Strategic Initiatives
9.4.3 BIO - RAD LABORATORIES, INC.
9.4.3.1 Company Overview
9.4.3.2 Financial Performance
9.4.3.3 Product Benchmarking
9.4.3.4 Strategic Initiatives
9.4.4 GE HEALTHCARE
9.4.4.1 Company Overview
9.4.4.2 Financial Performance
9.4.4.3 Product Benchmarking
9.4.4.4 Strategic Initiatives
9.4.5 THERMO FISHER SCIENTIFIC, INC.
9.4.5.1 Company Overview
9.4.5.2 Financial Performance
9.4.5.3 Product Benchmarking
9.4.5.4 Strategic Initiatives
9.4.6 BRUKER CORPORATION
9.4.6.1 Company Overview
9.4.6.2 Financial Performance
9.4.6.3 Product Benchmarking
9.4.6.4 Strategic Initiatives
9.4.7 F. HOFFMANN-LA ROCHE LTD.
9.4.7.1 Company Overview
9.4.7.2 Financial Performance
9.4.7.3 Product Benchmarking
9.4.7.4 Strategic Initiatives
9.4.8 PROMEGA CORPORATION
9.4.8.1 Company Overview
9.4.8.2 Financial Performance
9.4.8.3 Product Benchmarking
9.4.8.4 Strategic Initiatives
9.4.9 MERCK KGAA.
9.4.9.1 Company Overview
9.4.9.2 Financial Performance
9.4.9.3 Product Benchmarking
9.4.9.4 Strategic Initiatives
9.4.10 DANAHER
9.4.10.1 Company Overview
9.4.10.2 Financial Performance
9.4.10.3 Product Benchmarking
9.4.10.4 Strategic Initiatives
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective
1.11.2 Objective
1.12 List of Abbreviations
CHAPTER 2 MARKET DEFINITIONS
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Summary
CHAPTER 4 GLOBAL PROTEOMICS MARKET VARIABLES, TRENDS, & SCOPE
4.1 Proteomics Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration And Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Rise In Geriatric Population Demanding Personalized Medicines
4.4.2 Growing Demand For Advanced Diagnostics In Targeted Disease Treatment
4.4.3 Growing Prevalence Of Target Diseases
4.4.4 Growing Demand For Therapeutic Medicines
4.4.5 Outbreak Of Covid-19
4.5 Market Restraint Analysis
4.5.1 Presence Of Ambiguous Regulatory Framework
4.5.2 High Procedure Costs
4.6 Porter’s Five Forces Analysis
4.7 SWOT Analysis
4.8 COVID-19 Impact Analysis
CHAPTER 5 PROTEOMICS MARKET - SEGMENT ANALYSIS, BY PRODUCT, 2018 - 2030 (USD MILLION)
5.1 Global Proteomics Market: Product Movement Analysis
5.2 Instruments
5.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Reagents & Consumables
5.3.1 Reagents & Consumables Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Services
5.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 PROTEOMICS MARKET - SEGMENT ANALYSIS, BY APPLICATION, 2018 - 2030 (USD MILLION)
6.1 Global Proteomics Market: Application Movement Analysis
6.2 Drug Discovery
6.2.1 Drug Discovery Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Clinical Diagnostics
6.3.1 Clinical Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Others
6.4.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 PROTEOMICS MARKET- SEGMENT ANALYSIS, BY TECHNOLOGY, 2018 - 2030 (USD MILLION)
7.1 Proteomics Market: Technology Movement Analysis
7.2 Microarray Instruments
7.2.1 Microarray Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 X-Ray Crystallography
7.3.1 X-Ray Crystallography Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4. Spectroscopy
7.4.1 Spectroscopy Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5 Chromatography
7.5.1 Chromatography Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6 Protein Fractionation Systems
7.6.1 Protein Fractionation Systems Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.7 Electrophoresis
7.7.1 Electrophoresis Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.8 Surface Plasma Resonance (Spr) Systems
7.8.1 Surface Plasma Resonance (Spr) Systems Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 8 PROTEOMICS MARKET: - SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
8.1 Proteomics Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.7. South Africa
8.7.1. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Public Companies
9.1.1 Company Market Position Analysis
9.1.2 Competitive Dashboard Analysis
9.1.3 Strategic Framework
9.2 Private Companies
9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
9.2.2 Regional Network Map
9.4 Company Profiles
9.4.1 ILLUMINA, INC.
9.4.1.1 Company Overview
9.4.1.2 Financial Performance
9.4.1.3 Product Benchmarking
9.4.1.4 Strategic Initiatives
9.4.2 AGILENT TECHNOLOGIES, INC.
9.4.2.1 Company Overview
9.4.2.2 Financial Performance
9.4.2.3 Product Benchmarking
9.4.2.4 Strategic Initiatives
9.4.3 BIO - RAD LABORATORIES, INC.
9.4.3.1 Company Overview
9.4.3.2 Financial Performance
9.4.3.3 Product Benchmarking
9.4.3.4 Strategic Initiatives
9.4.4 GE HEALTHCARE
9.4.4.1 Company Overview
9.4.4.2 Financial Performance
9.4.4.3 Product Benchmarking
9.4.4.4 Strategic Initiatives
9.4.5 THERMO FISHER SCIENTIFIC, INC.
9.4.5.1 Company Overview
9.4.5.2 Financial Performance
9.4.5.3 Product Benchmarking
9.4.5.4 Strategic Initiatives
9.4.6 BRUKER CORPORATION
9.4.6.1 Company Overview
9.4.6.2 Financial Performance
9.4.6.3 Product Benchmarking
9.4.6.4 Strategic Initiatives
9.4.7 F. HOFFMANN-LA ROCHE LTD.
9.4.7.1 Company Overview
9.4.7.2 Financial Performance
9.4.7.3 Product Benchmarking
9.4.7.4 Strategic Initiatives
9.4.8 PROMEGA CORPORATION
9.4.8.1 Company Overview
9.4.8.2 Financial Performance
9.4.8.3 Product Benchmarking
9.4.8.4 Strategic Initiatives
9.4.9 MERCK KGAA.
9.4.9.1 Company Overview
9.4.9.2 Financial Performance
9.4.9.3 Product Benchmarking
9.4.9.4 Strategic Initiatives
9.4.10 DANAHER
9.4.10.1 Company Overview
9.4.10.2 Financial Performance
9.4.10.3 Product Benchmarking
9.4.10.4 Strategic Initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 Regulatory Framework
Table 3 Global proteomics market estimates and forecasts by products, 2018 - 2030 (USD Million)
Table 4 Global proteomics market estimates and forecasts by application, 2018 - 2030 (USD Million)
Table 5 Global proteomics market estimates and forecasts by technology, 2018 - 2030 (USD Million)
Table 6 Proteomics market- Key market restraint
Table 7 Global proteomics instruments market by region, 2018 - 2030 (USD Million)
Table 8 Global proteomics reagents & consumables market by region, 2018 - 2030 (USD Million)
Table 9 Global proteomics services market by region, 2018 - 2030 (USD Million)
Table 10 Global proteomics drug discovery market by region, 2018 - 2030 (USD Million)
Table 11 Global proteomics clinical diagnostics market by region, 2018 - 2030 (USD Million)
Table 12 Global proteomics others by region, 2018 - 2030 (USD Million)
Table 13 Global proteomics microarray instruments by region, 2018 - 2030 (USD Million)
Table 14 Global proteomics x-ray crystallography by region, 2018 - 2030 (USD Million)
Table 15 Global proteomics spectroscopy by region, 2018 - 2030 (USD Million)
Table 16 Global proteomics chromatography by region, 2018 - 2030 (USD Million)
Table 17 Global proteomics protein fractionation systems by region, 2018 - 2030 (USD Million)
Table 18 Global proteomics electrophoresis by region, 2018 - 2030 (USD Million)
Table 19 Global proteomics surface plasma resonance (SPR) systems by region, 2018 - 2030 (USD Million)
Table 20 North America proteomics market by country, 2018 - 2030 (USD Million)
Table 21 North America proteomics market by products, 2018 - 2030 (USD Million)
Table 22 North America proteomics market by application, 2018 - 2030 (USD Million)
Table 23 North America proteomics market by technology, 2018 - 2030 (USD Million)
Table 24 U.S. proteomics market by products, 2018 - 2030 (USD Million)
Table 25 U.S. proteomics market by application, 2018 - 2030 (USD Million)
Table 26 U.S. proteomics market by technology, 2018 - 2030 (USD Million)
Table 27 Canada proteomics market by products, 2018 - 2030 (USD Million)
Table 28 Canada proteomics market by application, 2018 - 2030 (USD Million)
Table 29 Canada proteomics market by technology, 2018 - 2030 (USD Million)
Table 30 Europe proteomics market by country, 2018 - 2030 (USD Million)
Table 31 Europe proteomics market by products, 2018 - 2030 (USD Million)
Table 32 Europe proteomics market by application, 2018 - 2030 (USD Million)
Table 33 Europe proteomics market by technology, 2018 - 2030 (USD Million)
Table 34 Germany proteomics market by products, 2018 - 2030 (USD Million)
Table 35 Germany proteomics market by application, 2018 - 2030 (USD Million)
Table 36 Germany proteomics market by technology, 2018 - 2030 (USD Million)
Table 37 U.K. proteomics market by products, 2018 - 2030 (USD Million)
Table 38 U.K. proteomics market by application, 2018 – 2030 (USD Million)
Table 39 U.K. proteomics market by technology, 2018 - 2030 (USD Million)
Table 40 Asia Pacific proteomics market by country, 2018 - 2030 (USD Million)
Table 41 Asia Pacific proteomics market by products, 2018 - 2030 (USD Million)
Table 42 Asia Pacific proteomics market by application, 2018 - 2030 (USD Million)
Table 43 Asia Pacific proteomics market by technology, 2018 - 2030 (USD Million)
Table 44 China proteomics market by products, 2018 - 2030 (USD Million)
Table 45 China proteomics market by application, 2018 - 2030 (USD Million)
Table 46 China proteomics market by technology, 2018 - 2030 (USD Million)
Table 47 Japan proteomics market by products, 2018 - 2030 (USD Million)
Table 48 Japan proteomics market by application, 2018 - 2030 (USD Million)
Table 49 Japan proteomics market by technology, 2018 - 2030 (USD Million)
Table 50 Latin America proteomics market by country, 2018 - 2030 (USD Million)
Table 51 Latin America proteomics market by products, 2018 - 2030 (USD Million)
Table 52 Latin America proteomics market by application, 2018 - 2030 (USD Million)
Table 53 Latin America proteomics market by technology, 2018 - 2030 (USD Million)
Table 54 Brazil proteomics market by products, 2018 - 2030 (USD Million)
Table 55 Brazil proteomics market by application, 2018 - 2030 (USD Million)
Table 56 Brazil proteomics market by technology, 2018 - 2030 (USD Million)
Table 57 MEA proteomics market by country, 2018 - 2030 (USD Million)
Table 58 MEA proteomics market by products, 2018 - 2030 (USD Million)
Table 59 MEA proteomics market by application, 2018 - 2030 (USD Million)
Table 60 MEA proteomics market by technology, 2018 - 2030 (USD Million)
Table 61 South Africa proteomics market by products, 2018 - 2030 (USD Million)
Table 62 South Africa proteomics market by application, 2018 - 2030 (USD Million)
Table 63 South Africa proteomics market by technology, 2018 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 Regulatory Framework
Table 3 Global proteomics market estimates and forecasts by products, 2018 - 2030 (USD Million)
Table 4 Global proteomics market estimates and forecasts by application, 2018 - 2030 (USD Million)
Table 5 Global proteomics market estimates and forecasts by technology, 2018 - 2030 (USD Million)
Table 6 Proteomics market- Key market restraint
Table 7 Global proteomics instruments market by region, 2018 - 2030 (USD Million)
Table 8 Global proteomics reagents & consumables market by region, 2018 - 2030 (USD Million)
Table 9 Global proteomics services market by region, 2018 - 2030 (USD Million)
Table 10 Global proteomics drug discovery market by region, 2018 - 2030 (USD Million)
Table 11 Global proteomics clinical diagnostics market by region, 2018 - 2030 (USD Million)
Table 12 Global proteomics others by region, 2018 - 2030 (USD Million)
Table 13 Global proteomics microarray instruments by region, 2018 - 2030 (USD Million)
Table 14 Global proteomics x-ray crystallography by region, 2018 - 2030 (USD Million)
Table 15 Global proteomics spectroscopy by region, 2018 - 2030 (USD Million)
Table 16 Global proteomics chromatography by region, 2018 - 2030 (USD Million)
Table 17 Global proteomics protein fractionation systems by region, 2018 - 2030 (USD Million)
Table 18 Global proteomics electrophoresis by region, 2018 - 2030 (USD Million)
Table 19 Global proteomics surface plasma resonance (SPR) systems by region, 2018 - 2030 (USD Million)
Table 20 North America proteomics market by country, 2018 - 2030 (USD Million)
Table 21 North America proteomics market by products, 2018 - 2030 (USD Million)
Table 22 North America proteomics market by application, 2018 - 2030 (USD Million)
Table 23 North America proteomics market by technology, 2018 - 2030 (USD Million)
Table 24 U.S. proteomics market by products, 2018 - 2030 (USD Million)
Table 25 U.S. proteomics market by application, 2018 - 2030 (USD Million)
Table 26 U.S. proteomics market by technology, 2018 - 2030 (USD Million)
Table 27 Canada proteomics market by products, 2018 - 2030 (USD Million)
Table 28 Canada proteomics market by application, 2018 - 2030 (USD Million)
Table 29 Canada proteomics market by technology, 2018 - 2030 (USD Million)
Table 30 Europe proteomics market by country, 2018 - 2030 (USD Million)
Table 31 Europe proteomics market by products, 2018 - 2030 (USD Million)
Table 32 Europe proteomics market by application, 2018 - 2030 (USD Million)
Table 33 Europe proteomics market by technology, 2018 - 2030 (USD Million)
Table 34 Germany proteomics market by products, 2018 - 2030 (USD Million)
Table 35 Germany proteomics market by application, 2018 - 2030 (USD Million)
Table 36 Germany proteomics market by technology, 2018 - 2030 (USD Million)
Table 37 U.K. proteomics market by products, 2018 - 2030 (USD Million)
Table 38 U.K. proteomics market by application, 2018 – 2030 (USD Million)
Table 39 U.K. proteomics market by technology, 2018 - 2030 (USD Million)
Table 40 Asia Pacific proteomics market by country, 2018 - 2030 (USD Million)
Table 41 Asia Pacific proteomics market by products, 2018 - 2030 (USD Million)
Table 42 Asia Pacific proteomics market by application, 2018 - 2030 (USD Million)
Table 43 Asia Pacific proteomics market by technology, 2018 - 2030 (USD Million)
Table 44 China proteomics market by products, 2018 - 2030 (USD Million)
Table 45 China proteomics market by application, 2018 - 2030 (USD Million)
Table 46 China proteomics market by technology, 2018 - 2030 (USD Million)
Table 47 Japan proteomics market by products, 2018 - 2030 (USD Million)
Table 48 Japan proteomics market by application, 2018 - 2030 (USD Million)
Table 49 Japan proteomics market by technology, 2018 - 2030 (USD Million)
Table 50 Latin America proteomics market by country, 2018 - 2030 (USD Million)
Table 51 Latin America proteomics market by products, 2018 - 2030 (USD Million)
Table 52 Latin America proteomics market by application, 2018 - 2030 (USD Million)
Table 53 Latin America proteomics market by technology, 2018 - 2030 (USD Million)
Table 54 Brazil proteomics market by products, 2018 - 2030 (USD Million)
Table 55 Brazil proteomics market by application, 2018 - 2030 (USD Million)
Table 56 Brazil proteomics market by technology, 2018 - 2030 (USD Million)
Table 57 MEA proteomics market by country, 2018 - 2030 (USD Million)
Table 58 MEA proteomics market by products, 2018 - 2030 (USD Million)
Table 59 MEA proteomics market by application, 2018 - 2030 (USD Million)
Table 60 MEA proteomics market by technology, 2018 - 2030 (USD Million)
Table 61 South Africa proteomics market by products, 2018 - 2030 (USD Million)
Table 62 South Africa proteomics market by application, 2018 - 2030 (USD Million)
Table 63 South Africa proteomics market by technology, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Proteomics market segmentation
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Proteomics market snapshot (2021)
Fig. 8 Market segmentation
Fig. 9 Penetration & growth prospect mapping
Fig. 10 Consumer behavior analysis
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Porter’s five forces analysis
Fig. 14 Proteomics market products outlook: Segment dashboard
Fig. 15 Proteomics market: Product movement analysis
Fig. 16 Instruments market, 2018 - 2030 (USD Million)
Fig. 17 Reagents & consumables market, 2018 - 2030 (USD Million)
Fig. 18 Respiratory diseases market, 2018 - 2030 (USD Million)
Fig. 19 Infectious diseases market, 2018 - 2030 (USD Million)
Fig. 20 Services market, 2018 - 2030 (USD Million)
Fig. 21 Proteomics market application outlook: Segment dashboard
Fig. 22 Proteomics market: Application movement analysis
Fig. 23 Drug discovery market, 2018 - 2030 (USD Million)
Fig. 24 Clinical diagnostics market, 2018 - 2030 (USD Million)
Fig. 25 Others market, 2018 - 2030 (USD Million)
Fig. 26 Proteomics market technology outlook: Segment dashboard
Fig. 27 Proteomics market: Technology movement analysis
Fig. 28 Microarray instruments market, 2018 - 2030 (USD Million)
Fig. 29 X-ray crystallography market, 2018 - 2030 (USD Million)
Fig. 30 Spectroscopy market, 2018 - 2030 (USD Million)
Fig. 31 Chromatography market, 2018 - 2030 (USD Million)
Fig. 32 Protein fractionation systems market, 2018 - 2030 (USD Million)
Fig. 33 Electrophoresis market, 2018 - 2030 (USD Million)
Fig. 34 Surface plasma resonance (SPR) systems market, 2018 - 2030 (USD Million)
Fig. 35 Regional market: Key takeaways
Fig. 36 Regional outlook, 2021 & 2030
Fig. 37 North America proteomics market, 2018 - 2030 (USD Million)
Fig. 38 U.S. proteomics market, 2018 - 2030 (USD Million)
Fig. 39 Canada proteomics market, 2018 - 2030 (USD Million)
Fig. 40 Europe proteomics market, 2018 - 2030 (USD Million)
Fig. 41 U.K. proteomics market, 2018 - 2030 (USD Million)
Fig. 42 Germany proteomics market, 2018 - 2030 (USD Million)
Fig. 43 Asia Pacific proteomics market, 2018 - 2030 (USD Million)
Fig. 44 Japan proteomics market, 2018 - 2030 (USD Million)
Fig. 45 China proteomics market, 2018 - 2030 (USD Million)
Fig. 46 Latin America proteomics market, 2018 - 2030 (USD Million)
Fig. 47 Brazil proteomics market, 2018 - 2030 (USD Million)
Fig. 48 MEA proteomics market, 2018 - 2030 (USD Million)
Fig. 49 South Africa proteomics market, 2018 - 2030 (USD Million)
Fig. 1 Proteomics market segmentation
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Proteomics market snapshot (2021)
Fig. 8 Market segmentation
Fig. 9 Penetration & growth prospect mapping
Fig. 10 Consumer behavior analysis
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Porter’s five forces analysis
Fig. 14 Proteomics market products outlook: Segment dashboard
Fig. 15 Proteomics market: Product movement analysis
Fig. 16 Instruments market, 2018 - 2030 (USD Million)
Fig. 17 Reagents & consumables market, 2018 - 2030 (USD Million)
Fig. 18 Respiratory diseases market, 2018 - 2030 (USD Million)
Fig. 19 Infectious diseases market, 2018 - 2030 (USD Million)
Fig. 20 Services market, 2018 - 2030 (USD Million)
Fig. 21 Proteomics market application outlook: Segment dashboard
Fig. 22 Proteomics market: Application movement analysis
Fig. 23 Drug discovery market, 2018 - 2030 (USD Million)
Fig. 24 Clinical diagnostics market, 2018 - 2030 (USD Million)
Fig. 25 Others market, 2018 - 2030 (USD Million)
Fig. 26 Proteomics market technology outlook: Segment dashboard
Fig. 27 Proteomics market: Technology movement analysis
Fig. 28 Microarray instruments market, 2018 - 2030 (USD Million)
Fig. 29 X-ray crystallography market, 2018 - 2030 (USD Million)
Fig. 30 Spectroscopy market, 2018 - 2030 (USD Million)
Fig. 31 Chromatography market, 2018 - 2030 (USD Million)
Fig. 32 Protein fractionation systems market, 2018 - 2030 (USD Million)
Fig. 33 Electrophoresis market, 2018 - 2030 (USD Million)
Fig. 34 Surface plasma resonance (SPR) systems market, 2018 - 2030 (USD Million)
Fig. 35 Regional market: Key takeaways
Fig. 36 Regional outlook, 2021 & 2030
Fig. 37 North America proteomics market, 2018 - 2030 (USD Million)
Fig. 38 U.S. proteomics market, 2018 - 2030 (USD Million)
Fig. 39 Canada proteomics market, 2018 - 2030 (USD Million)
Fig. 40 Europe proteomics market, 2018 - 2030 (USD Million)
Fig. 41 U.K. proteomics market, 2018 - 2030 (USD Million)
Fig. 42 Germany proteomics market, 2018 - 2030 (USD Million)
Fig. 43 Asia Pacific proteomics market, 2018 - 2030 (USD Million)
Fig. 44 Japan proteomics market, 2018 - 2030 (USD Million)
Fig. 45 China proteomics market, 2018 - 2030 (USD Million)
Fig. 46 Latin America proteomics market, 2018 - 2030 (USD Million)
Fig. 47 Brazil proteomics market, 2018 - 2030 (USD Million)
Fig. 48 MEA proteomics market, 2018 - 2030 (USD Million)
Fig. 49 South Africa proteomics market, 2018 - 2030 (USD Million)
